Nancy Hurtado‐Ziola

2.4k total citations · 1 hit paper
13 papers, 1.9k citations indexed

About

Nancy Hurtado‐Ziola is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Nancy Hurtado‐Ziola has authored 13 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Nancy Hurtado‐Ziola's work include Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (1 paper). Nancy Hurtado‐Ziola is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (1 paper). Nancy Hurtado‐Ziola collaborates with scholars based in United States, Netherlands and Sweden. Nancy Hurtado‐Ziola's co-authors include Ajit Varki, Victor Nizet, Darius Ghaderi, Andrew L. Doedens, Emmanuel A. Theodorakis, Richard L. Gallo, Carole Peyssonnaux, Vivekanand Datta, Randall S. Johnson and Thorsten Cramer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Nancy Hurtado‐Ziola

13 papers receiving 1.9k citations

Hit Papers

HIF-1α expression regulat... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIF-1α expression regulates the bactericidal capacity of phagocytes
    2005 566 citations Carole Peyssonnaux, Vivekanand Datta et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Hurtado‐Ziola United States 13 1.1k 797 286 267 230 13 1.9k
J. Michael McDaniel United States 23 1.5k 1.3× 1.1k 1.4× 99 0.3× 162 0.6× 129 0.6× 29 2.8k
Nadia Malagolini Italy 30 1.7k 1.5× 711 0.9× 330 1.2× 103 0.4× 237 1.0× 75 2.4k
Ileana Quinto Italy 26 1.1k 1.0× 688 0.9× 182 0.6× 429 1.6× 236 1.0× 78 2.1k
Jacques Bara France 30 1.2k 1.1× 554 0.7× 507 1.8× 84 0.3× 169 0.7× 107 2.6k
Tony S. Mondala United States 19 1.1k 1.0× 424 0.5× 232 0.8× 81 0.3× 316 1.4× 26 2.0k
Randall W. Barton United States 18 665 0.6× 620 0.8× 254 0.9× 155 0.6× 392 1.7× 42 1.9k
Partha S. Chowdhury United States 22 1.2k 1.1× 887 1.1× 690 2.4× 302 1.1× 121 0.5× 55 2.4k
Takushi Tadakuma Japan 26 828 0.7× 815 1.0× 186 0.7× 93 0.3× 145 0.6× 86 2.0k
Pamela A. Norton United States 27 1.1k 1.0× 256 0.3× 123 0.4× 240 0.9× 409 1.8× 56 2.2k
Shraga Segal Israel 28 986 0.9× 1.7k 2.1× 274 1.0× 368 1.4× 172 0.7× 90 3.1k

Countries citing papers authored by Nancy Hurtado‐Ziola

Since Specialization
Citations

This map shows the geographic impact of Nancy Hurtado‐Ziola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hurtado‐Ziola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hurtado‐Ziola more than expected).

Fields of papers citing papers by Nancy Hurtado‐Ziola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Hurtado‐Ziola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hurtado‐Ziola. The network helps show where Nancy Hurtado‐Ziola may publish in the future.

Co-authorship network of co-authors of Nancy Hurtado‐Ziola

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Hurtado‐Ziola. A scholar is included among the top collaborators of Nancy Hurtado‐Ziola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Hurtado‐Ziola. Nancy Hurtado‐Ziola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Padler‐Karavani, Vered, Nancy Hurtado‐Ziola, Yung‐Chi Chang, et al.. (2013). Rapid evolution of binding specificities and expression patterns of inhibitory CD33‐related Siglecs in primates. The FASEB Journal. 28(3). 1280–1293. 66 indexed citations
2.
Padler‐Karavani, Vered, Xuezheng Song, Hai Yu, et al.. (2012). Cross-comparison of Protein Recognition of Sialic Acid Diversity on Two Novel Sialoglycan Microarrays. Journal of Biological Chemistry. 287(27). 22593–22608. 101 indexed citations
3.
Ghaderi, Darius, Mai Zhang, Nancy Hurtado‐Ziola, & Ajit Varki. (2012). Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnology and Genetic Engineering Reviews. 28(1). 147–176. 248 indexed citations
4.
Padler‐Karavani, Vered, Nancy Hurtado‐Ziola, Minya Pu, et al.. (2011). Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer. Cancer Research. 71(9). 3352–3363. 112 indexed citations
5.
Soto, Paula C., Lance L. Stein, Nancy Hurtado‐Ziola, Stephen Μ. Hedrick, & Ajit Varki. (2010). Relative Over-Reactivity of Human versus Chimpanzee Lymphocytes: Implications for the Human Diseases Associated with Immune Activation. The Journal of Immunology. 184(8). 4185–4195. 46 indexed citations
6.
Cohen, Miriam, Nancy Hurtado‐Ziola, & Ajit Varki. (2009). ABO blood group glycans modulate sialic acid recognition on erythrocytes. Blood. 114(17). 3668–3676. 57 indexed citations
7.
Carlin, Aaron F., Yung‐Chi Chang, Thomas Areschoug, et al.. (2009). Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. The Journal of Experimental Medicine. 206(8). 1691–1699. 134 indexed citations
8.
Diaz, Sandra, Vered Padler‐Karavani, Darius Ghaderi, et al.. (2009). Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid In Human Tissues and Biotherapeutic Products. PLoS ONE. 4(1). e4241–e4241. 123 indexed citations
9.
Chokhawala, Harshal A., Shengshu Huang, Kam Lau, et al.. (2008). Combinatorial Chemoenzymatic Synthesis and High-Throughput Screening of Sialosides. ACS Chemical Biology. 3(9). 567–576. 72 indexed citations
10.
Linden, Els C.M. Brinkman-Van der, Nancy Hurtado‐Ziola, Toshiyuki Hayakawa, et al.. (2007). Human-specific expression of Siglec-6 in the placenta. Glycobiology. 17(9). 922–931. 94 indexed citations
11.
Nguyen, Dzung, Nancy Hurtado‐Ziola, Pascal Gagneux, & Ajit Varki. (2006). Loss of Siglec expression on T lymphocytes during human evolution. Proceedings of the National Academy of Sciences. 103(20). 7765–7770. 160 indexed citations
12.
Peyssonnaux, Carole, Vivekanand Datta, Thorsten Cramer, et al.. (2005). HIF-1α expression regulates the bactericidal capacity of phagocytes. Journal of Clinical Investigation. 115(7). 1806–1815. 566 indexed citations breakdown →
13.
Gagneux, Pascal, et al.. (2003). Human-specific Regulation of α2–6-linked Sialic Acids. Journal of Biological Chemistry. 278(48). 48245–48250. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Michael McDaniel Breakdown of academic impact, for papers by Nadia Malagolini Breakdown of academic impact, for papers by Ileana Quinto Breakdown of academic impact, for papers by Jacques Bara Breakdown of academic impact, for papers by Tony S. Mondala Breakdown of academic impact, for papers by Randall W. Barton Breakdown of academic impact, for papers by Partha S. Chowdhury Breakdown of academic impact, for papers by Takushi Tadakuma Breakdown of academic impact, for papers by Pamela A. Norton Breakdown of academic impact, for papers by Shraga Segal
Rankless by CCL
2026